PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -25.00 | -5.92% | 397.50 | 390.00 | 405.00 | 422.50 | 372.50 | 422.50 | 129,699 | 16:12:30 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -11.2 | -26.2 | - | 186 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/1/2021 | 15:12 | ALNC |  Faron Notes "Remarkable" Observations From Bexmarilimab Trial |
| 20/1/2021 | 14:06 | UKREG | Faron Pharmaceuticals Oy Second Price Monitoring Extn |
| 20/1/2021 | 14:01 | UKREG | Faron Pharmaceuticals Oy Price Monitoring Extension |
| 20/1/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Bexmarilimab (Clevegen) development update |
| 18/1/2021 | 14:05 | UKREG | Faron Pharmaceuticals Oy Second Price Monitoring Extn |
| 18/1/2021 | 14:00 | UKREG | Faron Pharmaceuticals Oy Price Monitoring Extension |
| 18/1/2021 | 11:06 | UKREG | Faron Pharmaceuticals Oy Second Price Monitoring Extn |
| 18/1/2021 | 11:01 | UKREG | Faron Pharmaceuticals Oy Price Monitoring Extension |
| 18/1/2021 | 10:22 | ALNC | Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment |
| 18/1/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy US Department of Defense to support TRAUMAKINE |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |
